1. Filipska A, Bohdan B, Wieczorek PP, Hudz N. Chronic Kidney Disease and Dialysis Therapy: Incidence and Prevalence in the World. Pharmacia. 2021;68(2):463-470. https://doi.org/10.3897/pharmacia.68.e65501
2. Соболев В.Е. Нефрология и урология домашней кошки (Felis catus). Российский ветеринарный журнал. Мелкие домашние и дикие животные. 2011;1:40-42.
3. Knoll T, Schönthaler M, Neisius A. Urolithiasis. Der Urologe. 2019;58:1271. https://doi.org/10.1007/s00120-019-01047-1
4. Kirkali Z, Rasooly R, Star RA, Rodgers GP. Urinary Stone Disease: Progress, Status, and Needs. Urology. 2015;86(4):651-653. https://doi.org/10.1016/j.urology.2015.07.006
5. Bacârea A, Fekete GL, Grigorescu BL, Bacârea VC. Discrepancy in Results between Dipstick Urinalysis and Urine Sediment Microscopy. Experimental and Therapeutic Medicine. 2021;21(5):538. https://doi.org/10.3892/etm.2021.9971
6. Gottlieb M, Long B, Koyfman A. The Evaluation and Management of Urolithiasis in the ED: A Review of the Literature. The American Journal of Emergency Medicine. 2018;36(4): 699-706. https://doi.org/10.1016/j.ajem.2018.01.003.
7. Hernandez N, Song Y, Noble VE, Eisner BH. Predicting Ureteral Stones in Emergency Department Patients with Flank Pain: An External Validation of the STONE Score. World Journal of Urology. 2016;34:1443-1446. https://doi.org/10.1007/s00345-016-1760-3
8. Safaie A, Mirzadeh M, Aliniagerdroudbari E, Babaniamansour S, Baratloo A. A Clinical Prediction Rule for Uncomplicated Ureteral Stone: The STONE Score; A Prospective Observational Validation Cohort Study. Turkish Journal of Emergency medicine. 2019;19(3):91-95. https://doi.org/10.1016/j.tjem.2019.04.001
9. Kopecny L, Palm CA, Segev G, Larsen JA, Westropp JL. Urolithiasis in Cats: Evaluation of Trends in Urolith Composition and Risk Factors (2005-2018). Journal of Veterinary Internal Medicine. 2021;35(3):1397-1405. https://doi.org/10.1111/jvim.16121
10. Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, et al. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review. The Journal of Urololy. 2017;198(2): 268-273. https://doi.org/10.1016/j.juro.2016.12.135
11. Ватников Ю.А., Миколенко О.Н., Вилковыский И.Ф., Паршина В.И., Трошина Н.И. Динамика биохимических показателей сыворотки крови при мочекаменной болезни у кошек. Лечение. Ветеринария, зоотехния и биотехнология. 2016;(12):48-54.
12. Мелешков С.Ф. Динамика функциональных расстройств мочеиспускания и их клинико-моРоссийская Федерацияологические параллели при урологическом синдроме у кошек. Ветеринарная патология. 2008;(3):48-55.
13. Almannie RM, Alsufyani AK, Alturki AU, Almuhaideb M, Binsaleh S, Althunayan AM, et al. Neural Network Analysis of Crystalluria Content to Predict Urinary Stone Type. Research and Reports in Urology. 2021;13:867-876. https://doi.org/10.2147/rru.S322580
14. Abufaraj M, Al Karmi J, Yang L. Prevalence and Trends of Urolithiasis among Adults. Current Opinion in Urology. 2022;32(4):425-432. https://doi.org/10.1097/mou.0000000000000994
15. Kaul E, Hartmann K, Reese S, Dorsch R. Recurrence Rate and Long-Term Course of Cats with Feline Lower Urinary Tract Disease. Journal of Feline Medicine and Surgery. 2020;22(6):544-56. https://doi.org/10.1177/1098612X19862887
16. Gomes VDR, Ariza PC, Borges NC, Schulz Jr. J, Fioravanti MCS. Risk Factors Associated with Feline Urolithiasis. Veterinary Research Communications. 2018;42(1):87-94. https://doi.org/10.1007/s11259-018-9710-8
17. Ушакова Т.М. Роль гепаторенальной системы в развитии метаболических нарушений у кошек, больных трипельфосфатным уролитиазом. Известия Оренбургского государственного аграрного университета. 2019;6(80):199-202.
18. Ушакова Т.М., Дерезина Т.Н. Урологический и клинический статусы кошек под действием комплексной фармакокоррекции уролитиаза на фоне диетотерапии. Вестник Донского государственного аграрного университета. 2018;(3-1(29)):5-12.
19. Ушакова Т.М., Старикова Е.А., Дерезина Т.Н. Комплексный алгоритм фармакокоррекции расстройств гепаторенальной системы у кошек, больных уролитиазом. Ветеринарная патология. 2019;(4):28-38.
20. Cleroux A, Alexander K, Beauchamp G, Dunn M. Evaluation for Association between Urolithiasis and Chronic Kidney Disease in Cats. Journal of the American Veterinary Medical Association. 2017;250(7): 770-774. https://doi.org/10.2460/javma.250.7.770
21. Burggraaf ND, Westgeest DB, Corbee RJ. Analysis of 7866 Feline and Canine Uroliths Submitted between 2014 and 2020 in the Netherlands. Research in Veterinary Science. 2021;137:86-93. https://doi.org/10.1016/j.rvsc.2021.04.026
22. Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM. Chronic Kidney Disease and the Gut Microbiome. American Journal of Physiology-Renal Physiology. 2019;316(6):F1211-F1217. https://doi.org/10.1152/ajprenal.00298.2018
23. Jacobson DK, Honap TP, Ozga AT, Meda N, Kagoné TS, Carabin, et al. Analysis of Global Human Gut Metagenomes Shows that Metabolic Resilience Potential for Short-Chain Fatty Acid Production is Strongly Influenced by Lifestyle. Scientific Reports. 2021;11:1724. https://doi.org/10.1038/s41598-021-81257-w
24. Mao L, Franke J. Symbiosis, Dysbiosis, and Rebiosis-The Value of Metaproteomics in Human Microbiome Monitoring. Proteomics. 2015;15:1142-1151. https://doi.org/10.1002/pmic.201400329
25. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, et al. Symbiotic Gut Microbes Modulate Human Metabolic Phenotypes. PNAS. 2008;105(6): 2117-2122. https://doi.org/10.1073/pnas.0712038105
26. Berg G, Rybakova D, Fischer D, Cernava T, Vergès MCC, Charles T, et al. Microbiome Definition Re-Visited: Old Concepts and New Challenges. Microbiome. 2020;8:103. https://doi.org/10.1186/s40168-020-00875-0